BiotechTube
Home/PaxMedica/Stephen Sheldon
SS

Stephen Sheldon

Chief Financial Officer

PaxMedica

Therapeutic Areas

NeurologyNeurodevelopmental Disorders

PaxMedica Pipeline

DrugIndicationPhase
PAX-101 (IV Suramin)Autism Spectrum Disorder (ASD)Phase 3

Leadership Team at PaxMedica

HW
Howard Weisman
Chief Executive Officer and Chairman
DH
David H. Koschitzki
Chief Operating Officer
View full PaxMedica profile